NM_001298.3:c.1228C>T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_001298.3(CNGA3):c.1228C>T(p.Arg410Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGA3 | ENST00000272602.7 | c.1228C>T | p.Arg410Trp | missense_variant | Exon 8 of 8 | 1 | NM_001298.3 | ENSP00000272602.2 | ||
CNGA3 | ENST00000436404.6 | c.1174C>T | p.Arg392Trp | missense_variant | Exon 7 of 7 | 1 | ENSP00000410070.2 | |||
CNGA3 | ENST00000409937.1 | n.1381C>T | non_coding_transcript_exon_variant | Exon 8 of 8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000400 AC: 10AN: 250286Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135384
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727130
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74284
ClinVar
Submissions by phenotype
Achromatopsia 2 Pathogenic:3
Variant summary: CNGA3 c.1228C>T (p.Arg410Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 250286 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CNGA3 causing Achromatopsia 2, allowing no conclusion about variant significance. c.1228C>T has been reported in the literature in multiple individuals affected with Cone Dystrophy or Achromatopsia 2. These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 35456422, 30682209). ClinVar contains an entry for this variant (Variation ID: 9479). Based on the evidence outlined above, the variant was classified as pathogenic. -
The CNGA3 c.1228C>T (p.Arg410Trp) variant was reported in six individuals with achromatopsia, including one individual who carries the variant in a homozygous state and five individuals, including a sibling pair, who carry the variant in a compound heterozygous state (Kohl et al. 1998; Wissinger et al. 2001; Nishiguchi et al. 2005; Genead et al. 2011; Liang et al. 2015). The variant was also identified in a homozygous state in an individual with cone dystrophy (Dockery et al. 2017). The p.Arg410Trp variant was absent from 190 control individuals (Kohl et al. 1998; Nishiguchi et al. 2005) and is reported at a frequency of 0.000089 in the Latino population of the Genome Aggregation Database. When transfected in HEK-293 cells, the p.Arg410Trp variant showed no cGMP channel activity, in contrast to the wild type protein, which showed maximum activity at the same vector concentration, and preliminary studies suggested that the channel function was not rescued when the p.Arg410Trp variant was co-expressed with wild type (Muraki-Oda et al. 2007). Tanaka et al. (2015) demonstrated that the canine orthologous variant, p.Arg424Trp, results in complete loss of channel activity and cone function in vivo, and structural modeling and molecular dynamics simulations suggested the variant disrupted a salt bridge formation. Based on the collective evidence, the p.Arg410Trp variant is classified as pathogenic for achromatopsia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
- -
not provided Pathogenic:2
Published functional studies showed no cGMP-activated current by patch-clamp recording technique, suggesting R410W may cause a loss of function of CNG channels (Muraki-Oda et al., 2007); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 9662398, 17693388, 30682209, 30337596, 31589614, 29099798, 25637600, 21778272, 26407004, 15712225, 11536077, 12187427, 12876837, 27040408) -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 410 of the CNGA3 protein (p.Arg410Trp). This variant is present in population databases (rs137852608, gnomAD 0.009%). This missense change has been observed in individuals with achromatopsia or cone dystrophy (PMID: 9662398, 11536077, 25637600, 29099798, 30337596). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg411Trp. ClinVar contains an entry for this variant (Variation ID: 9479). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CNGA3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CNGA3 function (PMID: 17693388). For these reasons, this variant has been classified as Pathogenic. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at